GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr | ₹1,678 Cr |
What is the latest Total Expenditure of GLAND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹4,332 Cr |
| Mar2024 | ₹2,600 Cr |
| Mar2023 | ₹2,891 Cr |
| Mar2022 | ₹2,161 Cr |
| Mar2021 | ₹1,678 Cr |
How is Total Expenditure of GLAND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,332 Cr | 66.61 | |
| Mar2024 | ₹2,600 Cr | -10.06 | |
| Mar2023 | ₹2,891 Cr | 33.78 | |
| Mar2022 | ₹2,161 Cr | 28.78 | |
| Mar2021 | ₹1,678 Cr | - | |
Compare Total Expenditure of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,024.2 Cr | -1.6% | -5.3% | 5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.6% |
-5.3% |
5.2% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses